Ana Aslan

The Ana Aslan National Institute of Gerontology and Geriatrics is a pioneering medical institution based in Bucharest, Romania, dedicated to the study of aging and the development of anti-aging treatments. Founded in 1952 by Dr. Ana Aslan, it was the first institute of its kind in the world and became a global destination for longevity treatments. The institute is most famous for developing Gerovital H3, a procaine-based therapy intended to treat age-related conditions such as arthritis, cardiovascular disease, and cognitive decline. Today, the institute continues to provide specialized geriatric care and conducts clinical research into regenerative medicine and chronic disease management. It operates multiple facilities, including a specialized clinic in Otopeni, and remains a central figure in the history of geriatric pharmacology.